Lymphomas: Essentials for Clinicians
The aim of this web section is to transform learning on lymphomas into an easy and enjoyable experience by using a very visual and didactic format…
The aim of this web section is to transform learning on lymphomas into an easy and enjoyable experience by using a very visual and didactic format…
Once-monthly garadacimab for more than 2 years in patients with hereditary angioedema was well tolerated and efficacious in reducing monthly attack rate and improving HRQoL.…
Here, we summarize a post hoc analysis of the IDHENTIFY trial investigating the molecular characteristics and prognostic impact of co-occurring mutations in patients with R/R…
Priyanka Mehta, MBBS, MD, FRCP, FRCPath, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, briefly discusses the real-world safety and efficacy data collected when using…
A 61-year-old man with chronic lymphocytic leukaemia maintained on oral venetoclax 400 mg daily presented to the emergency department with oral lesions, worsening lymphadenopathy, and…
Currently patients with a form of the disease which has spread to one or two other parts of the body are assumed to be resistant…
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced…
A multipeptide vaccine combination approach with 12MP plus 6MHP vs 12MP plus tet extended overall survival in patients with stage IIB to IV melanoma.
No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay.
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
Acalabrutinib combination therapy elicits statistically significant improvement in progression-free survival for treatment-naive mantle cell lymphoma.